HNX:DP3 Revenue

In the year 2024, Central Pharmaceutical Joint Stock Company No3 had annual revenue of 417.49B VND with 1.89% growth. Central Pharmaceutical Joint Stock Company No3 had revenue of 116.18B in the quarter ending December 31, 2024, with 18.55% growth.

Revenue

417.49B

Revenue Growth

+1.89%

P/S Ratio

2.97

Revenue / Employee

n/a

Employees

n/a

Market Cap

1,240.55B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	417.49B	7.75B	1.89%
Dec 31, 2023	409.73B	-75.34B	-15.53%
Dec 31, 2022	485.07B	104.00B	27.29%
Dec 31, 2021	381.08B	-14.64B	-3.70%
Dec 31, 2020	395.72B	-15.71B	-3.82%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Joint Stock Commercial Bank for Foreign Trade of Vietnam	65.33T
Joint Stock Commercial Bank for Investment and Development of Vietnam	59.17T
FPT Corporation	62.85T
Vietnam Joint Stock Commercial Bank for Industry and Trade	49.38T
Vietnam Technological and Commercial Joint Stock Bank	42.91T
Hoa Phat Group JSC	138.86T
Vinhomes JSC	102.05T
Petrovietnam Gas Joint Stock	103.56T

Revenue Rankings